PRKN and diabetes mellitus: Due to the emerging links between OXPHOS, neurological disorders (e.g., Alzheimer and Parkinson), and diabetes (Lima et al. 2014; De Felice and Ferreira 2014; Santiago and Potashkin 2014), it is tempting to hypothesize that the identified PARK2 polymorphisms could impact the risk of such human diseases.